Division of Orthopaedics, Department of Trauma and Orthopaedic Surgery, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.
Department for Arthroplasty, Asklepios Orthopaedic Hospital Lindenlohe, Lindenlohe 18, 92421, Schwandorf, Germany.
Trials. 2022 Aug 29;23(1):716. doi: 10.1186/s13063-022-06662-6.
Osteoarthritis (OA) is one of the most common disabilities in the elderly. When conservative management fails, total joint arthroplasty (TJA) is the treatment of choice for end-stage OA. Since quality and durability of implants has steadily improved, pre -and postsurgical processes moved into the focus of research. Hence, eHealth approaches offer an opportunity to provide a more available continuity of care. Regarding individualized pre-, peri-, and postsurgical stages, eHealth is expected to improve patient engagement, self-care, and outcomes across the surgical pathway. Aim of this study is to evaluate the effectiveness of the eHealth application "alley" as an adjuvant intervention to TJA. The app provides comprehensive information to empower patient with hip or knee OA to prepare and accompany them for their TJA surgery. Our primary hypothesis is that the pre- and postoperative adjuvant use of the eHealth application "alley" (intervention group, IG) leads to improved functional outcome.
Prospective, randomized, controlled, multi-center trial including n = 200 patients diagnosed with hip and n = 200 patients with knee OA (n = 200) scheduled for TJA. Patients of both groups will be randomly assigned to one of two study arms. Patients in the intervention group will receive access to the functions of the "alley" app. The app presents informative (e.g., information about osteoarthritis), organizational (e.g., information about medical rehabilitation), and emotional/empowerment (e.g., information about the relationship between mood and pain) content. Patients evaluate their condition and functional level by means of standardized digitally questionnaires. Patients in the control group will not receive any functions of the app. Assessments will be performed at baseline before, 10 days after, 1 months after, 3 months after, 6 months after, and 12 months after TJA. Primary outcome is change from baseline measured by the Hip Osteoarthritis Outcome Score or Knee injury and Osteoarthritis Outcome Score 3 months after TJA. The statistical analysis (t-test for independent variables with effect size Cohen's d) is performed separately for patients with TKA and THA.
Overall, the study aims to improve the understanding of the benefits of eHealth applications in the treatment of elderly patients with knee or hip arthroplasty. The approach is novel since a health care companion is combined with a digital information platform enabling direct and continuous feedback from the patients to the therapeutic treatment team. As the study investigate the effectiveness under everyday conditions, it is not feasible to control whether the patients in the IG read the educational information of the app respectively the control group consume additional information from other sources. However, this increases the external validity of the study if significant effects for the app can be demonstrated.
German Clinical Trials Register: DRKS00025608. Registered on 21 June 2021.
骨关节炎(OA)是老年人最常见的残疾之一。当保守治疗失败时,全关节置换术(TJA)是治疗终末期 OA 的首选方法。由于植入物的质量和耐用性稳步提高,术前和术后过程成为研究的焦点。因此,电子健康方法提供了提供更便捷的连续护理的机会。在个体化的术前、术中和术后阶段,电子健康有望改善患者在整个手术过程中的参与度、自我护理和治疗效果。本研究旨在评估电子健康应用程序“alley”作为 TJA 辅助干预的有效性。该应用程序为患有髋关节或膝关节 OA 的患者提供全面的信息,使他们能够为 TJA 手术做好准备并陪伴他们。我们的主要假设是,术前和术后辅助使用电子健康应用程序“alley”(干预组,IG)可改善功能结果。
这是一项前瞻性、随机、对照、多中心试验,纳入 n=200 例髋关节和 n=200 例膝关节 OA 患者(n=200),计划接受 TJA。两组患者将随机分配到两个研究组之一。干预组的患者将获得“alley”应用程序的功能。该应用程序提供了信息性内容(例如,有关骨关节炎的信息)、组织性内容(例如,有关医学康复的信息)和情感/赋权性内容(例如,有关情绪与疼痛之间关系的信息)。患者通过标准化的数字问卷评估自己的病情和功能水平。对照组的患者将不会获得应用程序的任何功能。评估将在 TJA 前、TJA 后 10 天、1 个月、3 个月、6 个月和 12 个月进行。主要结局是 TJA 后 3 个月时通过髋关节骨关节炎结局评分或膝关节损伤和骨关节炎结局评分测量的从基线的变化。(独立变量的 t 检验,效果大小 Cohen's d)分别针对 TKA 和 THA 患者进行统计分析。
总的来说,该研究旨在提高对电子健康应用在治疗老年膝关节或髋关节置换患者中的益处的理解。该方法是新颖的,因为它将医疗保健伴侣与数字信息平台相结合,使患者能够直接并持续地向治疗团队反馈。由于该研究在日常条件下进行,因此无法控制 IG 中的患者是否阅读了应用程序的教育信息,或者对照组是否从其他来源消费了额外的信息。然而,如果可以证明该应用程序具有显著效果,这将增加研究的外部有效性。
德国临床试验注册处:DRKS00025608。注册于 2021 年 6 月 21 日。